Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) Short Interest Update

Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) saw a significant drop in short interest during the month of January. As of January 31st, there was short interest totalling 3,200 shares, a drop of 50.8% from the January 15th total of 6,500 shares. Based on an average daily trading volume, of 475,300 shares, the days-to-cover ratio is presently 0.0 days.

Biodexa Pharmaceuticals Stock Performance

Shares of Biodexa Pharmaceuticals stock traded down $0.22 during trading on Thursday, hitting $4.58. 95,884 shares of the stock were exchanged, compared to its average volume of 842,053. Biodexa Pharmaceuticals has a 12 month low of $3.50 and a 12 month high of $74.00. The company has a fifty day moving average of $4.35.

Biodexa Pharmaceuticals Company Profile

Biodexa Pharmaceuticals Plc, a clinical stage biopharmaceutical company, focuses on developing a pipeline of products for the treatment of Type 1 diabetes and rare/orphan cancers of the brain. Its lead product candidate Tolimidone, a selective activator of the lyn kinase enzyme, currently under Phase II studies for the treatment of Type 1 diabetes.